about
Corticosteroids for the management of cancer-related pain in adultsMedically assisted nutrition for adult palliative care patientsMedically assisted hydration for adult palliative care patientsCorticosteroids for the management of cancer-related pain in adultsMedically assisted hydration for adult palliative care patientsThe role and significance of nurses in managing transitions to palliative care: a qualitative study.Effects of opioids and sedatives on survival in an Australian inpatient palliative care population.Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol.Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trialsValidation of a fentanyl transdermal adhesion scoring tool for use in clinical practice.Neuropathic pain: are we out of the woods yet?Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care.Negotiating palliative care in the context of culturally and linguistically diverse patients.Therapeutic challenges in cancer pain management: a systematic review of methadone.Pharmacological options for the management of refractory cancer pain-what is the evidence?Interventional options for the management of refractory cancer pain--what is the evidence?Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery).On resilience and acceptance in the transition to palliative care at the end of life.Integration of oncology and palliative care: setting a benchmark.Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility study.Medical specialists' motivations for referral to specialist palliative care: a qualitative study.Opioid conversion ratios used in palliative care: is there an Australian consensus?Prospective audit of short-term concurrent ketamine, opioid and anti-inflammatory ('triple-agent') therapy for episodes of acute on chronic pain.Specialists' experiences and perspectives on the timing of referral to palliative care: a qualitative study.Intranasal sufentanil for cancer-associated breakthrough pain.Negotiating futility, managing emotions: nursing the transition to palliative care.The troubles of telling: managing communication about the end of life.Impact of opioid therapy on sleep and respiratory patterns in adults with advanced cancer receiving palliative care.The meaning and experience of bereavement support: A qualitative interview study of bereaved family caregivers.Assessing the practice of palliative care doctors: what driving advice do they give patients with advanced disease?Corticosteroids as Co-analgesics With Opioids for Cancer-Related Pain: A Feasibility Study.Locating care at the end of life: burden, vulnerability, and the practical accomplishment of dying.Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion.Symptom Clusters in Men With Castrate-Resistant Prostate Cancer.Nutrition and hydration in dying patients: the perceptions of acute care nurses.The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 TrialPrioritising drugs for single patient (n-of-1) trials in palliative careThe Impact of Provision of Professional Language Interpretation on Length of Stay and Readmission Rates in an Acute Care Hospital SettingRe: efficacy, safety, and ethical validity of palliative sedation therapy
P50
Q24186400-4DFA7FC8-D99B-45CB-8DF6-5F55F40CF121Q24195010-1BEEE56B-3F09-40CA-973A-1B2E6D7623FBQ24195013-7964C058-CE3D-4C91-8422-2D99AB5A105FQ24197861-B7554CF5-9D9A-4BA5-A0FD-32F944E1B842Q24242918-53F78D2F-82BD-479D-9377-A97FBA301F84Q30588552-F7B0DEC8-B820-4508-9306-40EF0E1948E6Q34443651-8F35E8DA-BACF-4C1C-84BB-5F9906DFF5D7Q34687238-5EB2E7C7-CD06-49B9-8035-C36D337E631BQ35029512-5152C213-8F07-43BA-9798-BCF1E8CF6450Q35530241-1519854A-6765-445C-B092-BD972D1AAF4BQ36460976-5BAA32BC-182E-498B-838C-00FD3459E951Q37798986-F8EE79CB-8985-4D07-B224-5E1B27754E4FQ38134155-93D7F925-5FB9-4762-BDB3-6AFC9523E4ECQ38237741-FD536177-CA72-49E2-8DED-41FED562D6A3Q38370071-75935B64-D94C-4173-9182-B7A74D2BC222Q38667463-9E42A27F-490A-4BDA-B525-FC5E0F2BBD82Q38697050-70B292B2-3CF0-4C99-8E9B-9A20269FE91DQ39267563-B6076F2C-E409-41C1-8096-F7BCCF80E4B8Q39282472-5184AB38-F53C-4FC1-BBE3-5D83185B3FFCQ40910978-121C8296-F429-4469-814C-85A538FAF321Q44140078-5DB1D6E1-23C5-4AB6-B73C-6B82C128D278Q44343663-1A6BF77D-BC7E-41F9-A413-873596058924Q44347860-69CCF362-4759-41DC-B2AA-C9651D34FCC6Q45878028-03C488D7-AD39-4BE5-945F-818719E95258Q46162572-9C5F12AF-A524-4A69-9182-743DFC166B38Q47583553-A96F9675-14C3-40AB-A3A5-DE28ABD914D6Q47608849-61DFE8DE-3D90-4583-B0ED-486A176F3BCFQ47656862-55677FEE-7CEC-4012-82B4-59258D4E302CQ47813726-62995A5B-EEF1-4B1C-A886-C6A2D5163BEDQ48171194-1ED5DFF1-54BA-4234-899B-755991172B32Q50057896-9DE57533-18CB-4A70-9841-B56CE688C79BQ50283985-9DBC9B26-E0EC-4BBC-AF6D-14C55C8A2E85Q50499184-01A18399-1EAE-435F-B772-830C808D72E6Q51174802-2D0E821C-17F9-4B0B-8268-1A455F19A342Q53730200-7D37AB03-CA7C-413F-9F0F-75DA740BB5D7Q54417869-78A2D11F-AD65-49CC-B041-A7A162B312A9Q57198091-2F560F4C-DCA5-46C1-B6E3-15EB0B6AC114Q57360777-C6C7E170-D1FF-4E7B-AC30-B5727FEE3650Q58104388-323D9E12-271E-421E-B091-7891EFDE60CFQ58660184-2BA99B5F-7A81-4AD7-AF4A-238588E0AF2E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Phillip Good
@ast
Phillip Good
@en
Phillip Good
@es
Phillip Good
@nl
Phillip Good
@sl
type
label
Phillip Good
@ast
Phillip Good
@en
Phillip Good
@es
Phillip Good
@nl
Phillip Good
@sl
prefLabel
Phillip Good
@ast
Phillip Good
@en
Phillip Good
@es
Phillip Good
@nl
Phillip Good
@sl
P106
P31
P496
0000-0002-8198-0375